Definite | $10,000,000 | (Aug 22, 2025)
WALLROUND | $4,873,008 | (Aug 22, 2025)
Method AI | $20,000,000 | (Aug 22, 2025)
Certified by Founder
Lodge
XyloCor Therapeutics, Inc.
start up
United States
- King of Prussia, Pennsylvania
- 09/01/2025
- Series B
- $67,500,000
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
- Industry Research Services
- Website https://www.xylocor.com/
- LinkedIn https://www.linkedin.com/company/xylocor-therapeutics-inc./
Therm | $3,600,000 | (Aug 22, 2025)
SugaROx | $1,341,635 | (Aug 22, 2025)
Molecular You | $5,000,000 | (Aug 22, 2025)
Verdata | $8,000,000 | (Aug 22, 2025)
Agenda Hero | $5,600,000 | (Aug 22, 2025)
The Better Meat Co. | $31,000,000 | (Aug 22, 2025)
CLIKA Inc. | Undisclosed Amount | (Aug 22, 2025)
Grid Aero | $6,000,000 | (Aug 22, 2025)
CVector | $1,500,000 | (Aug 22, 2025)